Sumitomo Forestry Co., Ltd. Revises FY2026 Earnings — Revenue Up, Net Profit Down 36.8%
Sumitomo Forestry Co., Ltd. (TSE:1911) has revised its full-year earnings forecast for the fiscal year ending December 2026, raising revenue guidance but significantly cutting profit expectations across all bottom-line metrics due to acquisition-related costs and deteriorating U.S. market conditions.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 2590.0bn | JPY 2950.0bn | +13.9% |
| Operating Profit | JPY 157.0bn | JPY 143.0bn | -8.9% |
| Ordinary Income | JPY 160.0bn | JPY 115.0bn | -28.1% |
| Net Profit | JPY 95.0bn | JPY 60.0bn | -36.8% |
| EPS | JPY 155.90/share | JPY 97.85/share | -37.3% |
The company attributed the mixed revision to its acquisition of Tri Pointe Homes, Inc., which boosts revenue projections but introduces substantial integration costs including goodwill amortization, acquisition-related expenses, and increased interest payments. Additionally, the U.S. residential housing business faces headwinds from persistently elevated mortgage rates and consumer uncertainty, prompting higher incentive spending to stimulate demand. U.S. real estate operations are expected to see reduced property sales volumes, and the company has recognized valuation losses on select limited-partnership investment projects following profitability reviews.
The revision underscores the near-term earnings pressure from the TPH acquisition integration and challenging U.S. market dynamics. While revenue growth reflects the enlarged business footprint, the sharp decline in ordinary income (keijo rieki)—a Japan-specific profit metric including non-operating items—and net profit signals that acquisition synergies have not yet offset integration costs and operational headwinds. International investors should monitor management’s progress on cost absorption and U.S. market stabilization in coming quarters.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.